The weight-loss drugs being tested in 2025: will they beat Ozempic?
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial of its experimental drug CagriSema — a combination of semaglutide and a medicine called cagrilintide. People on CagriSema lost about 23% of their body weight in a 68-week study, outperforming both drugs when taken alone.
There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...
Praise for someone’s appearance after losing weight can inadvertently reinforce harmful societal standards. It can also ...
Even if you’re not on a weight loss journey yourself, there are plenty of ways you can help your partner achieve their ...
A half-cup serving of canned pineapple (in water) provides an excellent source of vitamin C, per the USDA. Vitamin C is a ...
Jelly Roll revealed that he recently climbed a mountain, something he said he would not have been able to do before dropping over 100 pounds.
Discover why people risk buying Ozempic and similar weight loss medications through social media, the devastating consequences, and legitimate ways to treatment ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
For an article about how weight-loss drugs affect marriage and intimacy, one health reporter worked with couples to “hold up a mirror to readers.” ...
Elderberry has been a go-to for people looking to give their immune system a boost around cold and flu season, thanks to the antioxidants found in the plant’s berries. But new research points to ...
Medical experts have identified specific factors that can make weight maintenance particularly challenging for Black women.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback